News
FAILURE OF THE DRUG SAFETY MONITORING SYSTEM
1+ day, 23+ hour ago (238+ words) I've been saying it since the start of the COVID scam'our drug safety monitoring system is completely broken. See my Substacks of 11 Nov 2023, 5 July 2023 and 6 May 2025. This system, like similar systems in all Western countries, is designed to detect and…...
Medincell: The European Medicines Agency Accepts Teva's Marketing Authorization Application for Olan
3+ day, 5+ hour ago (361+ words) The olanzapine long-acting injectable (TEV-749 / mdc-TJK) is designed to deliver the efficacy of olanzapine in a subcutaneous formulation1 administered every four weeks. If approved, TEV-749 could help fill a significant unmet need in available schizophrenia treatment options by addressing the lack…...
FAQs on Mifepristone Safety, Access, Current Legislation, and the Pharmacist's Role
2+ day, 6+ hour ago (715+ words) This FAQ was fact-checked by Sally Rafie, Pharm D, APP, BCPS, FCCP, FCPh A. Pharmacists now play a critical role not only in dispensing and ensuring compliance with the FDA's Risk Evaluation and Mitigation Strategies (REMS) program, but also in counseling…...
Teva Pharmaceuticals and Medincell Announce EMA Acceptance of Olanzapine Long-Acting Injectable TEV-749 for Schizophrenia Treatment
3+ day, 5+ hour ago (317+ words) Teva and Medincell announce EMA acceptance of TEV-749 for schizophrenia, a long-acting injectable olanzapine. TEV-749 is a long-acting injectable formulation of olanzapine for treating schizophrenia in adults. TEV-749 offers a subcutaneous injection every four weeks, addressing challenges with daily oral…...
EMA accepts Teva's application for long-acting olanzapine By Investing. com
3+ day, 8+ hour ago (307+ words) Updated May 21, 2026 23: 00 TEL AVIV & PARIS - Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) and Medincell (Euronext: MEDCL) announced today that the European Medicines Agency has accepted their Marketing Authorization Application for olanzapine long-acting injectable (TEV-749) for treating schizophrenia in adults,…...
The mifepristone whiplash story and how to cover it
6+ day, 5+ hour ago (474+ words) AI and Patient Safety How I Pitched It "Price and Profits:" An essential certification course Fellowships and Study Groups The legal fight over mifepristone has entered yet another volatile phase." In early May 2026, the 5th U. S. Circuit Court of Appeals ruled that…...
International Biosimilars Updates - May 2026
6+ day, 10+ hour ago (495+ words) On April 21, 2026, Biocon announced that Health Canada granted a Notice of Compliance (NOC) for BOSAYATM (denosumab) and VEVZUOTM (denosumab), biosimilars of Amgen's Prolia" (denosumab) and Xgeva" (denosumab). .. .By: Goodwin International Biosimilars Updates - May 2026 On April 21, 2026, Biocon announced that Health Canada…...
What is mifepristone?
1+ week, 6+ hour ago (775+ words) Mifepristone was approved by the US Food and Drug Administration decades ago and has been shown to be safe and effective. Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women's Reproductive Clinic,…...
Portugal developing medication intelligent system
1+ week, 16+ hour ago (516+ words) A project, scientifically coordinated by the Polytechnic Institute of Leiria, aims to create an intelligent system to support therapeutic adherence, making medication intake safer, more autonomous, and more closely monitored, said researcher Marisa da Costa Gaspar. By TPN/Lusa, in…...
Acting FDA commissioner promises transparency, action on abortion pill * World Net Daily * by Elizabeth Troutman Mitchell, The Daily Signal
1+ week, 1+ day ago (57+ words) ...